Comparison of Different Treatment Methods in Patella Chondromalacia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Gamze Demircioglu, PhD
- Phone Number: 05348689544
- Email: gamzekantardemircioglu@gmail.com
Study Locations
-
-
None Selected
-
Istanbul, None Selected, Turkey, 34353
- Recruiting
- Gamze Demircioğlu
-
Contact:
- Gamze Demircioğlu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- 18-65 years of age.
- Being diagnosed with chondromalacia
- Participate in the work on a voluntary basis
- Obtaining informed consent from them
Exclusion criteria:
- Fracture, ligament or muscle tear in the lower extremity within the last 3 months.
- Having a systemic disease
- Having a serious injury in the last 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: The rehabilitation group.
rehabilitation group.
|
In the rehabilitation group, patella mobilisation, muscle strengthening exercises, range of motion exercises will be performed 3 days a week with a therapist for 3 sessions per week
|
|
Active Comparator: The home exercise group
|
Participants in both groups will be included in a 3-week treatment programme.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WOMAC
Time Frame: 3 weeks
|
The Turkish version of the WOMAC scale will be used to evaluate the pain, stiffness and physical function of the individuals included in the study.
The score of each section is calculated within itself and the total score varies between 0 and 100.
High scores indicate an increase in pain and stiffness and impairment in physical function (12,13).
|
3 weeks
|
|
Stair climbing test
Time Frame: 3 weeks
|
Stair ascent and descent test: The patient's ascent and descent time of the 11-step staircase with a height of 14 cm and a depth of 29 cm were recorded separately with a stopwatch.
|
3 weeks
|
|
Range of motion of the joint
Time Frame: 3 weeks
|
Knee joint range of motion will be measured with a goniometer.
|
3 weeks
|
|
Star balance test
Time Frame: 3 weeks
|
The test is a simple but time-consuming test in terms of its application and is used to measure dynamic postural balance (1).
The test is based on the ability to reach the farthest possible distance on the supporting leg with the free foot in 8 different directions
|
3 weeks
|
|
Horizontal jump test
Time Frame: 3 weeks
|
They jump to the farthest distance they can jump using their single and double legs and the best result obtained after at least 2 trials is recorded in cm.
In this test, it should be noted that when contact with the ground after the jump, the measurement should be made at the heel level of the back foot, which is close to the starting line.
Another point to be considered is that the participant should be stationary at the starting line.
The participant cannot come to the line running and jump.
But it is allowed to make a springing movement in front of the line
|
3 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- E-10840098-772.02-7994
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.